impact factor, citescore
logo
 

One year in review

 

One year in review 2017: fibromyalgia


1, 2, 3, 4, 5, 6, 7

 

  1. Rheumatology Unit, ASST-Fatebenefratelli-L. Sacco University Hospital, Milan, Italy.
  2. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  3. Department of Internal Medicine and Medical Specialities, Division of Rheumatology, Sapienza University of Rome, Italy.
  4. Habilita, Care & Research Rehabilitation Institutes, EFIC Pain School, Department of High Technology Rehabilitation & Pain Rehabilitation Unit, Zingonia di Ciserano, Bergamo, Italy.
  5. Rheumatology Unit, ASST-Fatebenefratelli-L. Sacco University Hospital, Milan, Italy.
  6. Rheumatology Unit, ASST-Fatebenefratelli-L. Sacco University Hospital, Milan, Italy.
  7. Rheumatology Unit, ASST-Fatebenefratelli-L. Sacco University Hospital, Milan, Italy. piercarlo.sarziputtini@unimi.it

CER10517
2017 Vol.35, N°3 ,Suppl.105
PI 0006, PF 0012
One year in review

Free to view
(click on article PDF icon to read the article)

PMID: 28681712 [PubMed]

Received: 13/04/2017
Accepted : 27/04/2017
In Press: 28/06/2017
Published: 28/06/2017

Abstract

Fibromyalgia (FM) is a complex syndrome characterised by chronic pain, fatigue and functional symptoms. Widespread pain is often its most typical feature, whereas other manifestations may be associated to various extents. Its aetiopathogenesis is still a matter of debate, but various pharmacological and non-pharmacological therapies are currently available for its treatment. We review the literature concerning the most recent findings relating to the aetiopathogenesis, assessment and treatment of FM published between January 2016 and January 2017.

Rheumatology Article